Skip to main content
. 2021 Jul 21;2(7):100352. doi: 10.1016/j.xcrm.2021.100352

Figure 1.

Figure 1

Serum antibody levels in rhLCV-naive rhesus macaques after infusion of anti-gH/gL mAbs (EnAbs) and anti-gp350 mAbs (BnAbs)

(A and B) Serum endpoint dilution titers for reactivity against recombinant gH/gL or gp350 expressed on EBV-negative B lymphoma cells for three individual animals infused with EnAb (A) or BnAbs (B) (left panels). Serum from three animals infused with a control mAb were non-reactive against gH/gL and gp350 (data not shown). Serum titers for gH/gL and gp350 reactivity in healthy humans and macaques with natural LCV infection using the same assay are shown for comparison (right panels, line indicates mean). Each data point represents at least two technical replicates.